The global market for Synthetic Biology was valued at US$19.7 Billion in 2024 and is projected to reach US$86.2 Billion by 2030, growing at a CAGR of 27.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The field of synthetic biology has made significant strides thanks to advancements in genetic engineering techniques such as CRISPR-Cas9, which have dramatically increased the precision, efficiency, and affordability of genome editing. Moreover, synthetic biology often relies on automated and computer-assisted techniques that allow for the high-throughput synthesis and testing of genetic variations. These capabilities facilitate rapid progress in developing biological solutions to issues in health, energy, and environmental management. For instance, synthetic biologists have engineered yeast cells that can produce complex drugs, like artemisinin for malaria treatment, and bacteria that can break down plastics into environmentally benign byproducts. The integration of artificial intelligence and machine learning with synthetic biology also holds the potential to unlock new discoveries and applications, further pushing the boundaries of what can be achieved.
The growth in the synthetic biology market is driven by several factors, including the increasing demand for sustainable solutions across various industries, the expansion of biotechnology applications, and significant investment in research and development. Environmental concerns and the need for sustainable production methods propel the use of synthetic biology in developing bio-based chemicals, materials, and fuels. This approach not only helps in reducing the ecological footprint but also in diminishing dependence on fossil fuels. In the pharmaceutical sector, synthetic biology techniques are being used to produce new and more effective therapies, especially as traditional drug discovery processes prove to be time-consuming and costly. The market is also bolstered by policy frameworks that support biotechnological advancements and by a growing workforce skilled in interdisciplinary sciences. Economic factors, including venture capital funding and governmental grants, continue to inject financial resources into the field, promoting innovative startups and scaling up of bio-engineered solutions. As such, the market is expected to see robust growth as synthetic biology transforms how materials, chemicals, and drugs are developed, offering vast improvements in efficiency, cost, and performance.
Global Synthetic Biology Market - Key Trends & Drivers Summarized
Synthetic biology is an interdisciplinary branch of science that combines principles from engineering, biology, chemistry, computer science, and genetics to design and construct new biological parts, devices, and systems. This field aims to redesign existing natural biological systems for useful purposes and to engineer novel organisms with desired functions. At its core, synthetic biology involves the synthesis of genetic material to create DNA sequences that do not exist in the natural world, which are then used to program organisms to perform specific tasks. Applications range from producing biofuels and pharmaceuticals to creating new materials and processing information biologically.The field of synthetic biology has made significant strides thanks to advancements in genetic engineering techniques such as CRISPR-Cas9, which have dramatically increased the precision, efficiency, and affordability of genome editing. Moreover, synthetic biology often relies on automated and computer-assisted techniques that allow for the high-throughput synthesis and testing of genetic variations. These capabilities facilitate rapid progress in developing biological solutions to issues in health, energy, and environmental management. For instance, synthetic biologists have engineered yeast cells that can produce complex drugs, like artemisinin for malaria treatment, and bacteria that can break down plastics into environmentally benign byproducts. The integration of artificial intelligence and machine learning with synthetic biology also holds the potential to unlock new discoveries and applications, further pushing the boundaries of what can be achieved.
The growth in the synthetic biology market is driven by several factors, including the increasing demand for sustainable solutions across various industries, the expansion of biotechnology applications, and significant investment in research and development. Environmental concerns and the need for sustainable production methods propel the use of synthetic biology in developing bio-based chemicals, materials, and fuels. This approach not only helps in reducing the ecological footprint but also in diminishing dependence on fossil fuels. In the pharmaceutical sector, synthetic biology techniques are being used to produce new and more effective therapies, especially as traditional drug discovery processes prove to be time-consuming and costly. The market is also bolstered by policy frameworks that support biotechnological advancements and by a growing workforce skilled in interdisciplinary sciences. Economic factors, including venture capital funding and governmental grants, continue to inject financial resources into the field, promoting innovative startups and scaling up of bio-engineered solutions. As such, the market is expected to see robust growth as synthetic biology transforms how materials, chemicals, and drugs are developed, offering vast improvements in efficiency, cost, and performance.
Scope of the Study
The report analyzes the Synthetic Biology market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments:
Tool (Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA), Chassis Organism); Technology (Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics, Other Technologies); Application (Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental, Other Applications).Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.Key Insights:
- Market Growth: Understand the significant growth trajectory of the Oligonucleotides & Synthetic DNA Tool segment, which is expected to reach US$39.5 Billion by 2030 with a CAGR of a 29.1%. The Enzymes Tool segment is also set to grow at 26.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $6.9 Billion in 2024, and China, forecasted to grow at an impressive 32.0% CAGR to reach $8.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Agilent Technologies, Inc., Amyris, Inc., Agrivida, Inc., ATG Biosynthetics GmbH, Algentech SAS and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Synthetic Biology Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Synthetic Biology Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Synthetic Biology Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Some of the 141 major companies featured in this Synthetic Biology market report include:
- Agilent Technologies, Inc.
- Amyris, Inc.
- Agrivida, Inc.
- ATG Biosynthetics GmbH
- Algentech SAS
- Arzeda
- AdvanceSyn
- Asimov, Inc.
- ArsenalBio
- Abiochem Biotechnology
- Accelerbiotics
- Antheia
- Ardra Bio
- Baccuico
- Absci Corp.
Table of Contents
I. METHODOLOGYMII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies, Inc.
- Amyris, Inc.
- Agrivida, Inc.
- ATG Biosynthetics GmbH
- Algentech SAS
- Arzeda
- AdvanceSyn
- Asimov, Inc.
- ArsenalBio
- Abiochem Biotechnology
- Accelerbiotics
- Antheia
- Ardra Bio
- Baccuico
- Absci Corp.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 442 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 19.7 Billion |
| Forecasted Market Value ( USD | $ 86.2 Billion |
| Compound Annual Growth Rate | 27.9% |
| Regions Covered | Global |
